Life Sciences
Strategic & Operational transformation from Lab to Patient
Mews Partners transforms Pharma, BioTech, Diagnostics and MedTech companies across the entire value chain – from R&D to Technical Operations (Manufacturing, Procurement, Supply Chain and Distribution) – combining strategic vision with deep industrial expertise to deliver measurable performance improvements in one of the most regulated and complex industries in the world.
HOW WE TRANSFORM LIFE SCIENCES OPERATIONS
01
Managing product and development complexity to accelerate innovation
Life sciences product portfolios are growing more complex every year – combination drug-device products, multi-indication therapies, market-specific formulations, and tightening regulatory requirements across jurisdictions. This complexity compounds throughout the development cycle: technology transfers fail, industrialisation timelines stretch, and alignment between R&D, manufacturing, and commercial teams often determines whether complexity is managed or compounded. The companies that master this are the ones that reach patients first.
Structure product strategy and R&D portfolio governance
Define prioritisation frameworks, stage-gate models, and cross-functional decision architectures that keep complex portfolios on track and aligned with market strategy and patient needs
Apply system engineering, design-to-X, and value analysis methods
Manage technical complexity through structured requirements management, trade-off analysis, modularity, and value engineering adapted to pharma and medical device environments
Manage the extended innovation ecosystem
Structure partnerships with CDMOs, startups, academic institutions, and technology providers to accelerate innovation whilst managing IP, knowledge transfer, and operational integration
Coordinate system complexity for connected and combination devices
Align software and hardware development lifecycles for medical devices and combination products, ensuring integrated validation and regulatory compliance across mechanical, electronic, and software components
Secure technology transfer from development to manufacturing
Bridge the gap between lab-scale and industrial-scale with structured transfer processes, scale-up planning, and risk mitigation strategies across internal sites and CDMO partners
02
Securing supply reliability and manufacturing performance at scale
Supply shortages in life sciences are not just a logistics problem – they are a patient safety issue and a regulatory liability. Pharma and MedTech supply chains operate under constraints that few other industries face: batch traceability, cold chain requirements, regulatory holds, and growing reliance on external manufacturing networks. Sovereignty pressures and geopolitical disruptions add further complexity to global distribution and clinical trial logistics.
Redesign Sales & Operations Planning processes
Build S&OP governance frameworks adapted to multi-country pharma operations, align demand forecasting with production capacity and distribution constraints
Optimise manufacturing strategy and site productivity
Define make-or-buy strategies, improve process efficiency through Lean and operational excellence methods, and support capacity planning across owned and outsourced networks
Structure CDMO and CMO partnerships
Design supplier management frameworks, technology transfer protocols, and performance monitoring systems for contract manufacturing organisations
Improve distribution and reduce supply shortages
Redesign inventory policies, network configurations, and replenishment strategies to balance service levels with working capital and shelf-life constraints
Secure supply chain operations for clinical trials
Design and manage the logistics of investigational products and comparators across multi-country trial networks, navigating regulatory, cold chain, and geopolitical constraints
03
Ensuring compliance and traceability across the product lifecycle
In Life Sciences, non-compliance is not a performance issue – it is an existential risk. Product recalls, regulatory holds, and data integrity failures destroy brand value and patient trust. The challenge is amplified by the diversity of regulatory frameworks across countries, product types, and manufacturing sites – requiring organisations to manage compliance not as a single standard but as a multi-dimensional, evolving landscape.
Implement PLM as the compliance backbone
Structure product lifecycle management platforms to ensure full traceability of product and process data across development, manufacturing, and post-market, meeting GxP expectations by design rather than by workaround
Build product and process data integrity frameworks
Define data governance models, master data structures, and validation protocols that ensure consistency across systems, sites, and regulatory jurisdictions
Manage product and process changes throughout the lifecycle
Deploy change management processes that maintain compliance whilst accommodating formulation updates, supplier changes, obsolescence, and market-specific requirements
Structure knowledge and methods management
Organise and safeguard the critical data, processes, methods, and tools that underpin regulatory compliance, reducing dependency on individual expertise and ensuring continuity across the organisation
04
Exploiting operational data to improve performance and patient outcomes
Life sciences companies generate vast quantities of data – from R&D experiments and clinical batches to manufacturing records and supply chain flows. Yet most organisations struggle to connect this data across functions. The real challenge is not collecting data; it is turning fragmented information into decision-ready intelligence that improves development speed, production efficiency, and ultimately patient care through connected devices, e-services, and better follow-up.
Define and deploy digital transformation roadmaps
Assess digital maturity, prioritise use cases by business impact, and structure implementation programmes from proof of concept to industrial scale
Digitalise laboratories and R&D environments
Connect R&D tools and data flows, build the digital backbone for knowledge management, and enable data-driven decision-making across research and innovation teams
Leverage AI and machine learning for operational performance
Apply data science to master data quality, demand forecasting, R&D efficiency, and manufacturing process optimisation
Deploy ERP and APS systems for pharma and MedTech operations
Implement and integrate enterprise planning, manufacturing, and supply chain systems tailored to the regulatory and process requirements of life sciences environments
05
Meeting decarbonation commitments across global supplier ecosystems
Pharmaceutical and medical device manufacturers face mounting pressure from EU Green Deal regulations, ESG reporting requirements, and investor expectations. But in an industry where Scope 3 emissions often dwarf direct footprints – driven by hundreds of CMOs, suppliers, and logistics partners – decarbonation is fundamentally a supply chain and ecosystem challenge, not an internal operations problem alone.
Evaluate carbon footprints and build reduction roadmaps
Measure Scope 1, 2, and 3 emissions across the value chain and define trajectories aligned with regulatory requirements and group commitments
Structure Scope 3 supplier engagement programmes
Segment the CMO and supplier base by carbon maturity, co-construct emission reduction plans, and implement CO₂ data governance frameworks
Embed sustainability into product and process design
Apply eco-design principles and environmental performance levers across R&D, manufacturing, packaging, and distribution
Build ESG measurement and reporting infrastructure
Design the data collection, governance, and reporting systems required to substantiate environmental commitments across complex multi-site organisations
06
Equipping the organisation and people to deliver transformation at pace
Life sciences companies are digitising, decarbonising, and restructuring their supply chains simultaneously – but organisations, skills, and ways of working have not kept pace. R&D, manufacturing, and commercial functions still operate in deep silos with misaligned KPIs and planning horizons. Critical scientific and regulatory expertise is concentrated in a shrinking talent pool. And transformation programmes fail not because the strategy is wrong, but because the organisation is not equipped to absorb the change.
Break down functional silos across the value chain
Design collaboration models and governance frameworks that align R&D, manufacturing, supply chain, and commercial teams around shared objectives, timelines, and decision points
Design target organisations for operational transformation
Define organisational structures, roles, and operating models that support new ways of working – whether driven by digital deployment, industrial restructuring, or post-merger integration
Build talent and competency management frameworks
Structure skills mapping, development pathways, and knowledge transfer mechanisms to attract, retain, and grow the critical profiles that life sciences organisations depend on
Lead change management for large-scale transformation programmes
Embed change management into operational transformation from day one, ensuring adoption, capability building, and sustainable performance beyond the project phase
Powered by Mews Labs
Mews Labs brings applied AI and data science to the specific operational challenges of life sciences – turning fragmented data into decision-ready intelligence across the value chain.
S&OP simulation and scenario modelling
Simulation tools that model demand variability, production constraints, and distribution scenarios across multi-country pharmaceutical supply chains, enabling planners to test strategies before committing resources.
Machine learning for master data quality
AI-driven algorithms that detect anomalies, duplicates, and inconsistencies in product and process master data, improving data integrity across PLM and ERP systems at scale.
Supply chain optimisation under pharma constraints
Mathematical optimisation models that balance service levels, inventory costs, and production capacity in environments where batch traceability and shelf-life management add layers of complexity.
AI-powered R&D and innovation analytics
Data science applications that accelerate research and innovation cycles, from experimental design optimisation to predictive analysis of development portfolio outcomes.
Explore our expertises
Many challenges sit at the intersection of strategy, operations, and technology. We bring together complementary practices to address them.
Selected Life Sciences projects
Scope 3 decarbonation and CMO supplier engagement
Challenge: With over 200 CMO sites worldwide, no Scope 3 roadmap existed and procurement decisions were disconnected from group CO₂ targets.
Full supplier engagement programme structured and delivered. 9 pilot CMOs onboarded, 6 engaged in active co-construction of emission reduction plans.
"EM&S has become Sanofi's role model on decarbonation topics." – Head of HSE, Sanofi
S&OP process redesign across 42 countries
Challenge: Redesign the Sales & Operations Planning process across a global footprint of 42 countries, replacing legacy planning tools and aligning demand forecasting with production and distribution.
New S&OP governance and RACI deployed. APS benchmark and RFP completed for SAP APO replacement. Pilot launched in 2 countries.
Our Life Sciences clients
Meet our experts
Our life sciences team combines deep sector knowledge with hands-on operational expertise across R&D, supply chain, manufacturing, digital transformation, and sustainability – serving pharma, biotech, and medical device companies across Europe.
From lab bench to patient – and every operational challenge in between
Whether you are mastering product development complexity, securing supply across global networks, or equipping your organisation to deliver transformation at pace, we bring the sector depth and hands-on expertise to make it happen.
Get in touch